Collection

Cardiovascular Biomarker Translational Research

Submission status
Open
Open for submission from
29 June 2023
Submission deadline
Ongoing
Biomarker translational research is the process of developing diagnostic, prognostic, and monitoring tools that can be used in clinical practice to improve patient outcomes. The goal of biomarker translational research is to bridge the gap between basic research findings and clinical practice. This research involves multiple stages, including discovery, validation, clinical evaluation, regulatory approval, and implementation, and requires collaboration between researchers from different fields, including basic scientists, clinicians, biostatisticians, and regulatory agencies. Biomarker translational research is critical for advancing precision medicine and improving patient care.

Editors

  • Craig Stolen Craig Stolen

    Craig Stolen

    Craig Stolen, PhD, is a Clinical Science Fellow within the Cardiac Rhythm Management division at Boston Scientific Corporation and is an Associate Editor for the Journal of Cardiovascular Translational Research. Dr. Stolen is primarily responsible for inventing, developing, and translating novel concepts for implantable devices into practical applications for clinical use. He possesses a specific interest in heart failure biomarkers and is currently working to design and clinically assess implanted multisensory monitors for early warning of acute decompensated heart failure.

Articles (5 in this collection)